Apollo Endosurgery (APEN) Reports Q4 Loss of $35.01/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St turns lower as crude spikes, chip stocks weigh
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts APEN Hot Sheet
Join SI Premium – FREE
Apollo Endosurgery (NASDAQ: APEN) reported Q4 EPS of ($35.01), versus ($23.98) reported last year. Revenue for the quarter came in at $15.4 million versus the consensus estimate of $8.16 million.
- Total revenue of $15.4 million
- Endo-bariatric sales of $7.6 million, up 26% year-over-year, including 9% growth in the U.S. and 50% international growth
- Completed reverse-merger with LPATH, Inc. (\"Lpath\"), raising $29.0 million; began trading on NASDAQ Global Market
For earnings history and earnings-related data on Apollo Endosurgery (APEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
- Piper Sandler, KeyBanc bullish on Generac’s expanding data center pipeline
- Aegon shareholders approve US redomiciliation at EGM
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
